Lorinda A. Burgess's most recent trade in Angiodynamic Inc was a trade of 17,675 Common Stock done . Disclosure was reported to the exchange on July 16, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Angiodynamic Inc | Lorinda A. Burgess | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2025 | 17,675 | 55,257 (0%) | 0% | 0 | Common Stock | |
| Stepan Co. | Lorinda A. Burgess | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2025 | 2,500 | 3,927 | - | - | Stock Awards | |
| Stepan Co. | Lorinda A. Burgess | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 10 | 1,427 | - | - | Stock Awards | |
| Angiodynamic Inc | Lorinda A. Burgess | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 20,541 | 37,582 (0%) | 0% | 0 | Common Stock | |
| Stepan Co. | Lorinda A. Burgess | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2024 | 1,396 | 1,396 | - | - | Stock Awards |